LIFX — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-10

• The Company measures certain non-marketable equity securities and warrant investments at fair value on a nonrecurring basis in accordance with ASC 321, Investment - Equity Securities. In April 2025, the SAFE investment in a related party (the “Related Party SAFE”) converted into shares of preferred …

• In May 2025, we entered into a series of transactions with Aura Consolidated Group, Inc. (“Aura”), which included a convertible note investment into Aura (“Convertible Note Investment”). We elected to apply the fair value option in accordance with ASC 825, Financial Instruments.

• Gain (loss) on change in fair value of investments relates to the change in fair value associated with the Convertible Note Investment and the observable price change upon the conversion of the Related Party SAFE into the Related Party Investment.

• Interest income consists of interest earned on our cash and cash equivalents balances received from bank deposits, money market funds, and short-term investments, as well as the amortization of discounts on our short-term investments and cash equivalents.

• Other income (expense), net consists of foreign currency exchange gains/(losses) related to the remeasurement of certain assets and liabilities of our foreign subsidiaries that are denominated in currencies other than the functional currency of the subsidiary, foreign exchange transaction gains/(los…

Text removed vs the prior filing · source: 10-Q · 2026-05-11

• In May 2025, we entered into a series of transactions with Aura Consolidated Group, Inc. (“Aura”), which included a convertible note investment into Aura (“Convertible Note Investment”). We elected to apply the fair value option in accordance with ASC 825, Financial Instruments and as a result, the …

• Interest income consists of interest earned on our cash and cash equivalents balances received from bank deposits, money market funds, and short-term investments.

• Other income (expense), net consists of foreign currency exchange gains/(losses) related to the remeasurement of certain assets and liabilities of our foreign subsidiaries that are denominated in currencies other than the functional currency of the subsidiary, foreign exchange transactions gains/(lo…

• Change in foreign currency translation adjustment(30)1 (3,100)%

• Subscription revenue increased $26.3 million, or 32%, during the three months ended March 31, 2026 as compared to the three months ended March 31, 2025, primarily due to 27% growth in Paying Circles and 17% growth in total subscriptions. Additionally, subscription revenue in the current period benef…

Text added vs the prior filing · source: 10-Q · 2026-08-10

• The market price of our CDIs and common stock has been, and may in the future be, volatile, or may decline regardless of our operating performance and you could lose all or part of your investment.

• The trading price of our CDIs on the ASX and of our common stock on the Nasdaq Global Select Market (“Nasdaq”) has been and may continue to be volatile, and could be subject to wide fluctuations. In addition, the trading volume in our CDIs and common stock has in the past and may in the future fluct…

• •public reaction to our press releases, announcements, and filings with the SEC and ASX;

• •fluctuations in market prices and trading volumes of technology;

• •changes in economic and political conditions, financial markets, and/or the technology industry;

Text added vs the prior filing · source: 10-Q · 2026-08-10

• On July 29, 2026, the Board amended and restated the Company’s Amended and Restated Bylaws (as so amended and restated, the “Amended and Restated Bylaws”), which becomes effective as of August 7, 2026. The Amended and Restated Bylaws, among other things, establish the position of Lead Independent Di…

• The foregoing summary of the Amended and Restated Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of the Company’s Amended and Restated Bylaws, as amended, a copy of which is filed as Exhibit 3.2 to this Quarterly Report on Form 10-Q and is incor…

• During the three months ended June 30, 2026, the following Section 16 Officer adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K of the Exchange Act:

• NameTitleActionAdoption DateExpiration DateTotal number of securities to be sold

Text removed vs the prior filing · source: 10-Q · 2026-05-11

• On March 13, 2026, Ms. Morin terminated her Rule 10b5-1 trading plan, originally adopted on December 1, 2025, prior to the execution of all scheduled trades. No shares of common stock were sold pursuant to Ms. Morin's terminated 10b5-1 trading plan.

• Additionally, during the three months ended March 31, 2026, the following Section 16 Officer adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K of the Exchange Act: